TGFBR1 and breast carcinoma: Moreover, the ALK4/ALK5 small molecule inhibitor EW-7197 has been reported to potently suppress breast cancer metastasis to the lungs (43), suggesting that its effects could be mediated, at least in part, through downregulation of IL13Rα2 expression.